In an attempt to relate the cardiac involvement symptoms of thiamine deficiency with biochemical changes, determinations were made of activities of pyruvate and 2-ketoglutarate dehydrogenases and levels of pyruvate, lactate, creatine phosphate, ATP, ADP and AMP in the heart, and pH, P02 and PCO2 in the blood, and to correlate these with heart weight, heart rate and electrocardiogram patterns at various stages of thiamine deficiency induced by thiamine deprivation, oxythiamine treat ment or pyrithiamine treatment. Pair-fed controls were used in order to rule out effects due to the inanition unavoidably associated with the deficiencies. The bradycardia and cardiac hypertrophy could not be related causally to blood acid-base changes, high levels of blood pyruvate and lactate, or deficiency of tissue energy parameters, creatine phos phate, ATP or ADP. The development of bradycardia was shown to be due to thiamine lack or antagonism in the early stages of deficiency and not to inanition. However, the marked drop in rate in the terminal stages was, to a great degree, due to semistarvation.
Bradycardia was shown to persist in deficient hearts during perfusion in vitro. Most of the changes in the electrocardiogram shown earlier were found to be due to inanition. The slowing of the heart rate appears to have no cause and effect relationship to the conduction processes reflected in the electro cardiogram.
The appearance and severity of both bradycardia and cardiomegaly parallel the decrease in activities of pyruvate and 2-ketoglu tarate dehydrogenases in the heart.
Acute thiamine deficiency in the rat results in death within 4 to 5 weeks after removal of vitamin B1 from the diet (1) . Terminal symptoms include anorexia with associated growth failure or weight loss (2) , bradycardia and cardiomegaly (3), electrocardiogram abnormalities (3, 4) , adrenal hypertrophy (5, 6) , elevation of blood pyruvate and lactate levels (7) and, under proper conditions, neurological disturbances, ataxia and convulsions (8) (9) (10) .
The biochemical basis for the overt signs of thiamine deprivation has been primarily attributed to reduced tissue levels of thiamine diphosphate, the active coenzyme for pyruvate dehydrogenase (11, 12) , 2-ketoglutarate dehydrogenase (13, 14) and transketolase enzymes (15) (16) (17) , although an additional role independent of its coenzyme function has been suggested within the central nervous system (18, 19) . The present study was designed to determine whether a correlation could be established between the order of appearance and severity of the observed symptoms of cardiac disfunction and some biochemical lesions. This objective was aided by the use of two thiamine antagonists, oxythiamine (OTh) and pyri thiamine (PTh), which produce different thiamine deficiency symptoms (5) . OTh results in marked anorexia and elevation of blood pyruvate, but no neurological disturbances have been observed. PTh, on the other hand, produces no eleva tion of blood pyruvate but is characterized by severe neurological disturbances (ataxia and convulsions). Since a prominent symptom of thiamine deficiency is anorexia and associated growth failure, appropriate pair-fed controls were used to help establish which symptoms were related to thiamine deprivation and which were due to the associated semi-starvation. MATERIALS AND METHODS The conversion factor C equalled 160 since 0.025g of wet heart tissue was assayed for 15 min. Determination of CP, ATP, ADP and AMP. Pentobarbital anesthetized rats (4.5mg pentobarbital/100g. body wt., i.p.) were artificially respirated with 100% oxygen through an endotracheal tube while the thoracic cavity was opened to expose the heart. A plastic collar was placed between the heart and the artificially respirated lungs and then the heart was compressed between the jaws of heart tongs cooled to the temperature of liquid nitrogen. The 1-2mm wafer thin heart was then chipped free of excess frozen blood and tissue. The frozen weight of the heart was then used as the wet weight. At no time was the heart allowed to Table  5 ). 
Care

RESULTS
Normal control, thiamine-deprived, oxythiamine and pyrithiamine-treated groups were prepared several times during the course of the study. At each repetition the various groups displayed a characteristic growth pattern (Fig. 2) . The normal control group gained weight continuously throughout the course of the experimental period. The thiamine-deprived rats gained weight at a normal rate until about the ninth day and then lost weight steadily so that by the 25th day they had regressed to their starting weight. When thiamine deprivation was continued to the 35th day, the rats were as much as 30g below starting weight and neurological symptoms (impaired righting reflex, drowsiness and ataxia) were occasionally observed. The oxythiamine-treated rats showed a small weight gain up to the 7th day but gradually lost weight thereafter and by the 21st day they appeared emaciated with arched back and unkempt fur. A characteristic symptom of the terminal Pyrithiamine-treated rats gained weight normally for the first 10days, then leveled off at about the 14th day before losing weight very rapidly. By the 19th day, ataxia and convulsions were always observed. Pair-fed control rats to the pyrithiamine-treated group were on reduced food intake from the 10-14th day and from the 15th day on received no food until they were sacrificed on the 19th day.
Terminal body and heart weights in Table 1 are compared for the various groups. In line with the much smaller body weights in the experimental groups, the total heart weights are also significantly smaller than in the ad lib controls. However, when calculated as per cent of body weight as in the last column, all three deficient groups showed a significant cardiac hypertrophy. That this is not due to edema is shown by the unchanged water content. The hypertrophy was confirmed in a second experiment using pair-fed controls (Table 2 ). Most Table 2 . Effect of experimental treatments on total, ventricular and atrial heart weight when compared to pair-fed control hearts.
a Mean•}standard error in grams.
of this hypertrophy in all three deficient groups was accounted for by an increase in ventricular weight. This is somewhat at variance with an earlier study (3) which showed a significant increase in atrial weight in the OTh-treated rats. The reason for this difference is not known unless it lies in the better control in the present study by the use of pair-fed controls. In Fig. 3 a nomogram has been constructed by plotting body weight against heart weight. From this, one can see that the pair-fed (partially starved) rats had lower heart weights than the ad lib controls. This makes the actual cardiac hypertrophy in the deficient groups even more pronounced. As shown in Figs. 4, 5 and 6, bradycardia of thiamine-deprived and antagonist treated animals first became apparent by the second week. This decrease in heart rate was significantly (p<0.05) different from both normal and pair-fed control values. The thiamine-deprived group (Fig. 4) showed a 14% reduction in heart rate from the second to the fourth week, and by the end of the fifth week a 36 decrease was observed. Four of the pair-fed control rats to the deficient group The results of electrocardiography of the various experimental groups using standard lead II are reported in Table 3 . On the 28th day of thiamine deprivation no significant change in any of the measured parameters was found. By the 35th day most of the thiamine-deprived rats were moribund and a significant change in the P-R, QRS, R-T, and P-T intervals was recorded when compared to normal control animals. However, the pair-fed control rats were also moribund due to semi-starvation and showed similar changes in the P-R, R-T and P-T intervals.
No change was observed in the QRS interval as was the case in the thiamine deprived group. The oxythiamine-treated rats showed no significant (p>0.05) ECG changes during the course of the whole experiment. When pyrithiamine treatment was carried to the point of ataxia, the P-wave was significantly (p<0.05) reduced in duration and the R-T interval lengthened. A comparison of pair-fed control animals indicates that prolonged semi-starvation has a more pronounced effect on the ECG than complete starvation. The R-wave amplitude in terminal thiamine-deprived, OTh and PTh-treated groups was 0.68, 0.50, and 0.30 mvolts respectively, but only the thiamine-deprived group differed significantly from the normal control value of 0.38 mvolts (p<0.05). The thiamine-deprived animals also showed occasional increases in S-wave am plitude which were associated with S-T segment depression or elevation. Progressive changes in cardiac PDH and 2-KGDH activities expressed as percent of normal control values are also represented in Figs. 4, 5 and 6. The Th-deprived group (Fig. 4) showed a slight decline in PDH activity by the first week but a significant reduction (p<0.05) did not occur until the second week. and C. J. G UBLER or 71% of control values (Figs. 6 and 7) . The terminal levels of PDH and 2-KGDH in the heart are shown in Fig. 7 . Both activities were significantly reduced in all three types of deficiency.
Terminal myocardial levels of creative phosphate (CP) and the adenosine phosphates (ATP, ADP and AMP) are presented in Table 4 . Levels of CP at various periods of deficiency are also plotted in Figs . 4, 5 and 6. Terminal levels of CP were elevated in both OTh-and PTh-treated rats , but this did not appear until the terminal stages. No change was observed in the levels of ATP , ADP or AMP in any of the treated groups unless the terminal drop in ADP in the OTh treated rats can be considered of more than borderline significance. An increase in cardiac pyruvate concentration was observed in both the thiamine-deprived and antagonist-treated rats (Table 4 ), but only those in the antagonist-treated groups were significantly increased (p<0.05). A statistically significant (p<0.05) increase in L-lactate was seen only in the thiamine-deprived group ( Table 4) .
As is evident from 
DISCUSSION
The present study clearly demonstrates that thiamine deprivation and pyrithiamine treatment result in an increase in the heart weight relative to body weight.
This hypertrophy was found not to be due to edema since the water content of the cardiac muscle in the various experimental groups was not significantly different.
The observed cardiomegaly in the thiamine deprived and antagonist-treated rats was associated with a slower heart rate.
The development of bradycardia during the early stage of thiamine deficiency was shown to be the result of thiamine lack and not due to gradual starvation.
However, the precipitous drop in heart rate seen during the agonal stage of thiamine deprivation was found to be partly the result of semi-starvation, since pair-fed control rats also showed a sharp drop in heart rate at ap-proximately the same time. DRURY et al. (29) came to a similar conclusion from their pair-fed study in relation to thiamine deprived rats. CHENEY et al. (3) showed that oxythiamine treatment produced bradycardia a week or more before the onset of acute symptoms, but pyrithiamine treatment did not produce bradycardia until convulsions were observed. GURTNER (30)observed bradycardia after oxythiamine treatment but not after pyrithiamine treatment. Bowever, he prepared his rats slightly differently from Cheney et al. and the present study and therefore his results are not directly comparable. Some evidence for the slowing of the heart rate in thiamine-related car diomyopathies was found in the rat electrocardiogram. However, ECG ir regularities were principally noted only during the terminal stages of thiamine deficiency. Many of the changes were due to the moribund condition of the animal since pair-fed rats also showed many of these abnormalities. Nevertheless, thiamine deficiency in the rat was found to cause a lengthening of the QRS complex and depression of the S-T segment, as well as an increase in the amplitude of the R-wave, (Table 3) . However, these changes were not observed until long after bradycardia was apparent which would indicate no direct cause and effect relationship. Additionally, the absence of any definite alteration in the conduction velocity of the rat myocardium as interpreted from the ECG at the time of the onset of bradycardia, suggests that the slow ing of the heart rate occurs earlier in the contractile process, probably at the pace-maker level (sino-atrial node). Supportive evidence for the conclusion that no consistent change in the ECG is responsible for the observed bradycardia comes from some earlier studies. DRURY et al. (29) found no change in the ECG of thiamine-deprived or pair-fed rats until a moribund condition resulted. HUNDLEY et al. (31) found prolonged P-R interval in 7 out of 20 acutely thiamine-deficient rats. YosHITosHI et al. (32) reported a 17.6% occurrence of arrhythmia in severely deficient rats.
The present study clearly demonstrates that myocardial PDH and 2-KGDH activities are markedly decreased during thiamine deprivation. Similarly, the two thiamine antagonists, oxythiamine and pyrithiamine were shown to produce a significant decrease in the activities of these two thiamine diphosphate dependent enzymes. Decreased PDH activity results in an increase in cardiac pyruvate and lactate levels. However, the accumulation of these end products of glycolysis within heart tissue was not as great as expected. Possibly, during thiamine deficiency, pyruvate enters the tricarboxylic acid cycle via carbon dioxide fixation rather than by decarboxylation. The finding of BENE VENGA et al. (33) that thiamine deficient calves incorporated more pyruvate into amino acids than normal calves supports this concept. Hence, the possible contribution of increased pyruvate carboxylase activity in the metabolism of thiamine deficient cardiac tissue should be examined.
Although cardiac PDH activity in thiamine deficient animals has been AND CARDIAC FUNCTION 51 extensively studied and has been shown to be significantly decreased (1, 21, 34) , the dependence of cardiac metabolism on this enzyme to satisfy its energy requirements might not be as extensive as previously thought. It has been shown that when fatty acids and glucose are perfused together through an isolated rat heart, the fatty acids are preferentially oxidized (35) . Insight into how this response might occur was initially provided by the observation of UN et al. (36) that the activity of PDH multienzyme-complex is con trolled by a phosphorylation-dephosphorylation reaction of one of its com ponents; pyruvate decarboxylase. Subsequent work carried out by WIELAND and his colleagues (37, 38) on isolated rat hearts perfused with glucose , demonstrated that as much as 70 % of the total measurable PDH activity was in the active (dephospho) form. However, the addition of fatty acids, ketone bodies or acetone to the perfusate reduced the metabolically active form to 30%. Similarly, overnight fasting decreased the active form of cardiac PDH to less than 15%. Because of these considerations, the 18 % total measurable PDH activity in ThD cardiac tissue, as reported in the present study, might possibly be sufficient for adequate cardiac function. Nevertheless, whether all of this remaining PDH activity is in the active form remains to be clarified . The 2-KGDH enzyme complex is analogous in the mechanism of action and cofactor requirements to that of PDH (39) . However, the mechanism of regulation of enzymatic activity is not yet fully understood, although cyclic AMP media tion has been suggested (40). Since 2-KGDH is an important enzyme in the Krebs cycle, decreased 2-ketoglutarate metabolism would be expected to impair cardiac energy synthesis from carbohydrate, fatty acid and amino acid sources. It Was therefore decided to relate the enzymatic activity of this enzyme to the energy content of the myocardium in which thiamine diphosphate requirement of 2-KGDH had been impaired. It was found that by the fourth week of thiamine-deprivation cardiac 2-KGDH was only 20% of the control value. However, the myocardial CP, ATP, ADP and AMP content of thiamine deficient rats was not significantly different from that of normal rats. These results indicate that neither reduced PDH nor 2-KGDH activity have an appreciable effect on cardiac energy synthesis. The possibility exists that, like pyruvate, 2-ketoglutarate might be metabolized by other thiamine independent enzymes . In the brain a shunt around the 2-KGDH step by way of gamma-amino butyrate has been demonstrated (41) . However, the contribution of this pathway in the thiamine deficient heart remains to be investigated. MCCANDLESS et al. (34) , in determining the energy status of the thiamine deficient heart , found the ATP content down 16.8% and 34.1% during the 4th and 5th weeks , respectively. Unfortunately, no values for cardiac CP were reported since they felt their values were too variable for valid conclusions. Additional support for the suggestion that decreased PDH and 2-KGDH activity does not necessarily adversely affect cardiac energy levels comes from the use of thiamine antagonists. The present study showed that oxythiamine and pyrithiamine-treatment both resulted in significant increases in cardiac CP stores even though PDH and 2-KGDH activities were significantly depressed. INOUE et al. (42) also found the CP content in thiamine deficient brains to be unchanged, while the ATP content increased. HOLOWACH et al. (43) reported that pyrithiamine treatment of the mouse brain resulted in an increase of CP and ATP concentrations. In the liver, pyrithiamine treat ment doubled the ATP content even though PDH and 2-KGDH activities were 25% and 50% of the normal values. SCHENKER et al. (44) found the renal cortex ATP level normal, while medullary content was decreased during severe thiamine deficiency. These results indicate that reduced PDH and 2-KGDH activities do not reduce the amount of high energy phos phates stored in the rat heart. The bradycardia of thiamine deficiency was not demonstrated to be the result of reduced energy for contraction since, in the case of oxythiamine or pyrithiamine-treated hearts, an actual increase in the available energy was observed. It is doubtful that reduced energy for contraction is the etiology of bradycardia in the rat since the thiamine deficient heart in human beriberi (8) and the anesthetized dog (45) are able to beat at a higher rate for long periods of time indicating that even during severe thiamine deficiency cardiac metabolism is able to satisfy the energy requirements of a rapidly beating heart.
The transketolase activity of the hexose monophosphate (HMS) shunt is also dependent on the coenzyme thiamine diphosphate. However, OPIE (46) , in reviewing the role of the HMS shunt in cardiac metabolism, indicated that the shunt was either quiescent or only moderately active in the myocardium. In addition, MCCANDLESS et al. (34) observed that the giving of thiamine to thiamine-deprived rats reversed the cardiac symptoms within 24hr but the transketolase activity remained at 40% of control values for up to 6days after recovery. In light of these considerations, the role of transketolase in the development of cardiac dysfunction in thiamine deficiency was not investigated in the present study.
Bradycardia, as observed in the thiamine deficient rat, has also been attri buted to the accumulation of pyruvate and lactate in the blood and within the myocardium (47) (48) (49) . In the present study, perfusionn of rat hearts from both normal and 4-week thiamine deficient animals with neutralized perfusion medium containing pyruvate and lactate levels similar to those reported for severely thiamine deficient rats resulted in only a slight alteration in heart rate that was not of the same magnitude as seen in the deficient animal. However, the force of contraction was significantly decreased in both groups.
The bradycardia of the thiamine deficient animal was found to persist in vitro and in the absence of active nervous innervation, which suggests that bradycardia of thiamine deficiency is myocardial in origin. However, the possibility that neural transmitter substances were not sufficiently cleared from the myoneural junction during the control perfusion of 5min is not excluded. An attempt to perfuse hearts of 5-week deficient animals that were in ataxia proved unsuccessful. The shock of excision and attachment to the perfusion apparatus either resulted in fibrillation, tachycardia or severe brady cardia. These findings suggest that elevated blood pyruvate and lactate levels are not the direct cause of bradycardia in thiamine deficiency.
The pH, PCO2 and PO2 determinations on the arterial blood of severely deficient rats were made to see if the increase in blood pyruvate and lactate had altered the acid-base balance, but no significant change from control values were noted. These findings therefore justified the use of neutralized perfusate solutions. The arterial hematocrit of severely thiamine deficient rats when compared to that of control animals of the same body size but of a younger age was found to be significantly increased. Future studies relating the appearance of bradycardia and cardiomegaly with hematocrit changes .are needed to assess more meaningfully the possible role of this response and the etiology of cardiac dysfunction in thiamine deficiency.
In summary, then, the appearance and degree of severity of bradycardia of thiamine deficiency was found to be correlated with the changess in enzymatic activities of cardiac PDH and 2-KGDH. However, no direct relationship between the heart rate and the energy content of the myocardium could be demonstrated. Additionally, no relationship between the tissue levels of pyruvate and lactate in the heart and the rate of the heart beat could be established. Perfusion of either normal or thiamine deficient hearts with either high or low levels of pyruvate and lactate was found to have no relationship to the in vitro heart rate. The heart changes observed in these studies include confirmation of cardiomegaly and ECG irregularities. The use of two thiamine anta gonists helped confirm the relationship between the degree of cardiac dysfunc tion and the coenzyme activity of thiamine.
